Mbl Wealth, LLC Abb Vie Inc. Transaction History

Mbl Wealth, LLC

$833 Million
Q2 2024

A detailed history of Mbl Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mbl Wealth, LLC holds 4,103 shares of ABBV stock, worth $726,025. This represents 0.08% of its overall portfolio holdings.

Number of Shares

4,103

Previous 4,150 1.13%

Holding current value

$726,025

Previous $755,000 6.89%

% of portfolio

0.08%

Previous 0.09%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$154.79 - $180.76 $7,275 - $8,495	-47 Reduced 1.13%	4,103 $703,000
Q1 2024 Apr 22, 2024	BUY	$159.82 - $182.1 $159 - $182	1 Added 0.02%	4,150 $755,000
Q4 2023 Jan 18, 2024	SELL	$137.6 - $154.97 $9,769 - $11,002	-71 Reduced 1.68%	4,149 $642,000
Q3 2023 Oct 11, 2023	BUY	$133.59 - $154.65 $71,069 - $82,273	532 Added 14.43%	4,220 $629,000
Q2 2023 Jul 17, 2023	SELL	$132.51 - $164.9 $3,047 - $3,792	-23 Reduced 0.62%	3,688 $496,000
Q1 2023 Apr 11, 2023	BUY	$144.61 - $166.54 $38,321 - $44,133	265 Added 7.69%	3,711 $591,000
Q4 2022 Jan 12, 2023	BUY	$138.31 - $165.87 $212,859 - $255,273	1,539 Added 80.7%	3,446 $557,000
Q3 2022 Jan 12, 2023	SELL	$134.21 - $153.93 $166,823 - $191,334	-1,243 Reduced 39.46%	1,907 $256,000
Q2 2022 Jan 12, 2023	BUY	$137.62 - $174.96 $37,157 - $47,239	270 Added 9.38%	3,150 $483,000
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $380,102 - $471,600	2,880 New	2,880 $467,000
Q3 2021 Oct 25, 2021	SELL	$106.4 - $120.78 $238,548 - $270,788	-2,242 Closed	0 $0
Q1 2021 May 27, 2021	BUY	$102.3 - $112.62 $229,356 - $252,494	2,242 New	2,242 $242,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mbl Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mbl Wealth, LLC with notifications on news.

Account